Nanobody-based Biepitope BCMA-targeted CAR-T cells

BCMA-targeted CAR-T cell therapy using nanobody-based biepitopes · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nanobody-based Biepitope BCMA-targeted CAR-T cells, covering 2024-07-16 to 2024-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM [Phase 1, Phase 2]

See pricing